You are here

Stemline Therapeutics

Biopharma takeovers show quantity, if not quality

EP Vantage

Mon, 07/13/20 - 11:13 am

Gilead Sciences

Portola Pharmaceuticals

Stemline Therapeutics

Tetra Therapeutics

Stemline Slated for Acquisition by Menarini in Deal Worth Up to $677M

Xconomy

Mon, 05/4/20 - 10:35 pm

Stemline Therapeutics

Acceleron, Stemline price upsized follow-ons

BioCentury

Wed, 01/16/19 - 11:57 am

Stemline Therapeutics

Elzonris tagraxofusp-erzs

Stemline's SL-401 significantly decreased the viability of malignant cells

The Fly on the Wall

Tue, 05/20/14 - 11:23 am

Stemline Therapeutics

Multiple Myeloma

A Year-End Look at 3 High-Flying Biotech IPOs of 2013: PETX, RCPT, STML

Motley Fool

Thu, 12/26/13 - 01:48 pm

Stemline Therapeutics

ASH Conference: 3 Companies To Watch

Seeking Alpha

Sun, 12/8/13 - 12:15 pm

Stemline Therapeutics

Stemline Therapeutics Announces the Presentation of Clinical Trial Results With a Synthetic Peptide Vaccine for Brain Cancer, Now Being Developed as SL-701, at the Society of Neuro-Oncology (SNO) Annual Meeting

Yahoo/Globe Newswire

Sat, 11/23/13 - 12:37 pm

Stemline Therapeutics